இந்தியன் நோயெதிர்ப்பு லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இந்தியன் நோயெதிர்ப்பு லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இந்தியன் நோயெதிர்ப்பு லிமிடெட் Today - Breaking & Trending Today

Indian Immunological Ltd to produce Covaxin materials from mid-June


Indian Immunological Ltd to produce Covaxin materials from mid-June
​ By
IANS
|
​ 0 Views
 
Kolkata: Health workers give the 1st dose of vaccine to the Government workers during increasing numbers of COVID 19 cases in Kolkata 24 May, 2021. (Photo: Kuntal Chakrabarty/ IANS). Image Source: IANS News
New Delhi, May 29 : In a bid to augment India s Covid-19 vaccine production, the Centre has decided to support some public sector companies with grants under Mission Covid Suraksha to help in this endeavour. One such company is the Hyderabad-based Indian Immunological Ltd (IIL), under the National Dairy Development Board.
A technical collaboration agreement has been reached between IIL and Bharat Biotech to supply the drug substance required for manufacturing of Covaxin to the latter, an official statement said. ....

Andhra Pradesh , New Delhi , Indian Immunologicals , Atmanirbhar Bharat , Rk Anand Kumar , National Dairy Development Board , Indian Immunological Ltd , Serum Institute Of India Covishield , Bharat Biotech Ltd , Mission Covid Suraksha , Department Of Biotechnology , Mission Covid Suraksha , Hyderabad Based Indian Immunological Ltd , National Dairy Development , Bharat Biotech , Bio Safety , Serum Institute , Drug Controller General , Emergency Use Authorisation , ஆந்திரா பிரதேஷ் , புதியது டெல்ஹி , கே ஆனந்த் குமார் , தேசிய பால் வளர்ச்சி பலகை , இந்தியன் நோயெதிர்ப்பு லிமிடெட் , பாரத் பயோடெக் லிமிடெட் , துறை ஆஃப் உயிரி தொழில்நுட்பவியல் ,

Sputnik V- Developed in Russia, Produced in Hyderabad


Apr 09, 2021, 15:39 IST
By M Somasekhar
When Hyderabad-based Pharma major, Dr Reddy’s announced that it was partnering the RIDF, Moscow to undertake clinical trials and distribute the Sputnik V vaccine in India in the September 2020, as the global pandemic was spreading fast, it raised both public and market interest. 
In March 2021, Dr Reddy’s says, its just weeks before the Vaccine could get clearance from Indian regulators for use. In the meantime, atleast half a dozen Indian drug majors have entered into tie-ups with the RIDF, the Russian Sovereign Fund for production. 
Interestingly, with four of these drug companies located in Hyderabad, the city is fast turning out to be the biggest Hub for the Russian Vaccine. Dr Reddy’s with its bold step is leading the pack with the others being Hetero Biopharma, Gland Pharma and Virchow Biotech. Each of these three companies will produce the vaccine. It may be noted that the representatives of the RIDF had ....

Andhra Pradesh , Zydus Cadila , Narendra Modi , Aurobindo Pharma , Adar Poonawala , Deepak Sapra , Stelis Biopharma , Oxford Astrazeneca , Services Of Dr Reddy , Union Health , India Professional Congress , Russian Sovereign Fund , Indian Immunological Ltd , Gemaleya National Research Institute Of Epidemiology , Serum Institute Of India , Hyderabad Based Pharma , Hetero Biopharma , Gland Pharma , Sputnikv Vaccine , Gemaleya National Research Institute , Bharat Biotech , Prime Minister , Tika Utsav , Serum Institute , Union Health Minister , Indian Govt ,